Further, ATRX loss was significantly associated with DRG2 downregulation in several other tumour types which are frequently ALT-positive, such as HGG, osteosarcoma, paraganglioma, and phaeochromocytoma (Supplementary Fig. S4A). Here, DRG2 is linked to neoplasm.